HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy (NCT06828588) | Vanderbilt-Ingram Cancer Center | 2026-04-16 |
| A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer (NCT01598077) | Novartis Pharmaceuticals | 2012-07-01 |
Track HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.